Maintain homologous schedules using the vaccines authorized for the different age groups (Sinopharm 3 and 4 years, Pfizer 5 to 11 years); Administer an additional dose in cases of immunocompromised hosts using the same vaccine as the one used previously; Wait for further evidence before recommending a booster dose in the 3 to 11 years age group; Work on the availability of vaccines at the jurisdictional level; Increase efforts to reach the unvaccinated population; Co-administration with other vaccines is recommended; Implement strategies for the recovery of coverage for routine vaccines schedule vaccines.
https://www.argentina.gob.ar/sites/default/files/2022/01/acta_conain_23_de_febrero_2022.pdf